ADMELOG

NDC 0024-5926 · Sanofi-Aventis U.S. LLC

Generic nameinsulin lispro

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)INSULIN LISPRO

Strength100 U/mL

Pharmacologic classInsulin Analog [EPC], Insulin [Chemical/Ingredient]

Marketing categoryBLA

Packages

0024-5926-05 — 1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL

J1817 — Insulin for administration through dme (i.e., insulin pump) per 50 units Medicare Part B payment limit (ASP + 6%): $3.06

FDA lists these products with the same active ingredient.

0002-7752 — Insulin lispro, 0002-8207 — Insulin lispro-aabc, 0002-8213 — Insulin lispro, 0002-8222 — Insulin lispro, 0002-8228 — Insulin lispro-aabc, 0002-8233 — Insulin lispro, 0002-8235 — Insulin lispro-aabc, 0002-8351 — Insulin lispro-aabc, 0002-8797 — Insulin lispro, 0002-8798 — Insulin lispro, 0002-8799 — Insulin lispro, 0024-5924 — insulin lispro, 0024-5925 — insulin lispro, 50090-1375 — Insulin lispro, 50090-1663 — Insulin lispro, 50090-4073 — Insulin lispro, 50090-4488 — Insulin lispro, 50090-5391 — Insulin lispro, 50090-7433 — Insulin lispro-aabc, 70518-4275 — insulin lispro, +8 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.